Indication
Nontuberculous Mycobacterial Pulmonary Infection
2 clinical trials
3 products
Product
OmadacyclineProduct
PlaceboClinical trial
A Ph. 2, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, & Tolerability of Oral Omadacycline in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus ComplexStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Clinical trial
Comparison Study of Unfavorable Treatment Outcome Between Mycobacterium Abscessus Infection in Patients With Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome Within 1 Year of Appropriate TreatmentStatus: Completed, Estimated PCD: 2023-09-30
Product
Appropriate treatment